January 31, 2018 / 12:39 PM / in 22 minutes BRIEF-Protalix Biotherapeutics' Pegunigalsidase Alfa Receives Fast Track Designation From FDA Reuters Staff 1 Min Read 
Jan 31 (Reuters) - Protalix Biotherapeutics Inc: 
* PROTALIX BIOTHERAPEUTICSâ€™ PEGUNIGALSIDASE ALFA RECEIVES FAST TRACK DESIGNATION FROM THE U.S. FOOD AND DRUG ADMINISTRATION Source text for Eikon: Further company coverage: